NASDAQ:ASMB

Assembly Biosciences Stock Predictions

Healthcare > Biotechnology

Buy ASMB

*Your capital is at risk

$24.57

+0.0800 (+0.327%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

ASMB Prediction Chart

ASMB Predictions History

Latest community submissions for ASMB.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
NameNotImportant Pro	Apr 22, 2019	$18.41 -90.13%	$15.55	X	81.61%	0
JS Pro	Nov 24, 2017	$38.71 -92.52%	$43.12	V	89.80%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ASMB with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ASSEMBLY BIOSCIENCES

Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical tri...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by